OTCMKTS:SDGCF Sundrug Co.,Ltd. (SDGCF) Stock Price, News & Analysis $28.18 0.00 (0.00%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartShort Interest About Sundrug Co.,Ltd. Stock (OTCMKTS:SDGCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sundrug Co.,Ltd. alerts:Sign Up Key Stats Today's Range$28.18▼$28.1850-Day Range$28.18▼$28.1852-Week Range$28.18▼$28.18VolumeN/AAverage Volume2,500 shsMarket CapitalizationN/AP/E Ratio0.12Dividend Yield169.99%Price TargetN/AConsensus RatingN/A Company OverviewSundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It operates drug stores that offers pharmaceuticals, cosmetics, and daily miscellaneous goods; and discount stores that sells foodstuffs, household goods, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.Read More… The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Sundrug Co.,Ltd. Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks21st Percentile Overall ScoreSDGCF MarketRank™: Sundrug Co.,Ltd. scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Sundrug Co.,Ltd..Read more about Sundrug Co.,Ltd.'s stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 133.70.Price to Earnings Ratio vs. SectorThe P/E ratio of Sundrug Co.,Ltd. is 0.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 131.93. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverSundrug Co.,Ltd. has a short interest ratio ("days to cover") of 405, which indicates bearish sentiment.Change versus previous monthShort interest in Sundrug Co.,Ltd. has recently decreased by 15.62%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldSundrug Co.,Ltd. pays a meaningful dividend of 1.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSundrug Co.,Ltd. does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Sundrug Co.,Ltd. is 20.98%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Sundrug Co.,Ltd.'s dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverSundrug Co.,Ltd. has a short interest ratio ("days to cover") of 405, which indicates bearish sentiment.Change versus previous monthShort interest in Sundrug Co.,Ltd. has recently decreased by 15.62%, indicating that investor sentiment is improving significantly. News and Social Media2.8 / 5News SentimentN/A News SentimentSundrug Co.,Ltd. has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Sundrug Co.,Ltd. this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Sundrug Co.,Ltd. insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 25.63% of the stock of Sundrug Co.,Ltd. is held by institutions.Read more about Sundrug Co.,Ltd.'s insider trading history. Receive SDGCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sundrug Co.,Ltd. and its competitors with MarketBeat's FREE daily newsletter. Email Address SDGCF Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com SDGCF Stock Analysis - Frequently Asked Questions How have SDGCF shares performed this year? Sundrug Co.,Ltd.'s stock was trading at $24.40 at the beginning of 2024. Since then, SDGCF shares have increased by 15.5% and is now trading at $28.18. View the best growth stocks for 2024 here. How do I buy shares of Sundrug Co.,Ltd.? Shares of SDGCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:SDGCF CUSIPN/A CIKN/A Webwww.sundrug.co.jp Phone(142) 369-6211FaxN/AEmployees6,371Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.12 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (OTCMKTS:SDGCF) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sundrug Co.,Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sundrug Co.,Ltd. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.